All News about Innate Pharma S.A. ADR
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_397.jpg)
![](https://mms.businesswire.com/media/20220104005828/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20220103005319/en/1245155/4/INNATEvertnoirDS.jpg)
Innate Pharma to Participate in Upcoming Investor Conferences
January 04, 2022
From Innate Pharma SA
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_524.png)
![](https://mms.businesswire.com/media/20211215005894/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2792.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_109.jpg)
![](https://mms.businesswire.com/media/20211209005158/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/laboratory-g91232d1d0_1920.jpg)
![](https://mms.businesswire.com/media/20211202005097/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
![](https://mms.businesswire.com/media/20211123006134/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20211115006329/en/1245155/4/INNATEvertnoirDS.jpg)
![](https://mms.businesswire.com/media/20211108006164/en/1245155/4/INNATEvertnoirDS.jpg)
From Innate Pharma SA
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3607.jpeg)
![](https://mms.businesswire.com/media/20211025005451/en/919602/4/INNATEvertnoirDS.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_3352.jpeg?width=720)
![](https://mms.businesswire.com/media/20211014005617/en/916406/4/INNATEvertnoirDS.jpg)
From Innate Pharma
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_2297.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_459.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_293.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_1808.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_21.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_1765.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/premkt_movers_453.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_291.png)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_1675.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-afternoon-market-update_30.jpg)
Mid-Afternoon Market Update: Nasdaq Down 1%; Protagonist Therapeutics Shares Plummet
September 17, 2021
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://g.foolcdn.com/editorial/images/643407/scientist-presenting-to-investors-getty.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.